Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...

BioView Ltd. , a company developing advanced medical imaging systems for cancer cell detection, traded on the Tel Aviv Stock Exchange, today announced the completion of the first stage of its joint ...

Researchers Identify Key Mechanism in Human Lung Development Oct. 31 ... The team showed promising ... Ultrasensitive Liquid Biopsy Tech Spots Cancer Earlier Than Standard Methods June 14 ...

AI Powered Blood Test Detects Earliest Stage of Breast Cancer: Study FindsA new screening method that combines laser analysis ...

A collaboration of scientists and doctors from the Champalimaud Foundation has obtained exciting imaging results that could ...

Docebo Inc. ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, is proud to announce that it has been awarded nine ...

a study of human biochemical individuality. Oncotarget. 2018;9(60):31664-31681. doi:10.18632/ oncotarget.25839 3. Da Cunha PA ...

The quail parfait glistens on my plate, smeared across a disc of fried heirloom masa. At first glance, it looks like the kind of fine-dining fare you’ll find at many high-end restaurants: a ...

In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...